You can buy or sell Incyte and other stocks, options, and ETFs commission-free!
Incyte Corp. Common Stock, also called Incyte, is a biopharmaceutical company, which engages in the discovery, development and commercialization of proprietary therapeutics. Its portfolio includes compounds in various stages, ranging from preclinical to late stage development, and commercialized products such as JAKAFI (ruxolitinib), and ICLUSIG (ponatinib). The company was founded by Roy A. Whitfield in April 1991 and is headquartered in Wilmington, DE. The listed name for INCY is Incyte Corp. Common Stock.
52 Week High
52 Week Low
Incyte Corp. stock rises Friday, outperforms market
Shares of Incyte Corp. INCY, +0.27% inched 0.27% higher to $78.66 Friday, on what proved to be an all-around poor trading session for the stock market, with the
— per share
Expected May 4, Pre-Market